1.
Dexmedetomidine reduces ventilator-induced lung injury (VILI) by inhibiting Toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB signaling pathway. Biomol Biomed [Internet]. 2018 May 20 [cited 2024 Apr. 29];18(2):162-9. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/2400